How do life sciences companies build sustainable manufacturing processes without jeopardizing quality and GMP compliance?
We develop and implement sustainable manufacturing strategies for regulated production: material flow analysis and Process Mass Intensity, green chemistry principles in synthesis, Scope 1-2-3 target setting for ESG reporting under the CSRD (Directive (EU) 2022/2464), and circularity concepts. The decisive hurdle is rarely the sustainability goal itself, but its sequencing against the validated state: a solvent substitution or equipment retrofit affects a GMP-validated process, and anyone who considers the change control path under the EU GMP Guidelines (EudraLex Volume 4) only after the technical selection loses the savings to a revalidation that could have been planned for early on.
- Pharma
- Biotech
- MedTech
- IVD
Overview
Why is sustainable production becoming mandatory in the life sciences sector?
Sustainability measures managed through the change control system of the EU GMP Guidelines · Process Mass Intensity and Scope 1-2-3 targets linked to CSRD reporting under Directive (EU) 2022/2464
Last updated: 2026-06-13
In a regulated environment, sustainability in production is no longer a voluntary extra. External reporting and reduction requirements are rising, while every measure touches a GMP-validated process that must be managed through the change control system of the EU GMP Guidelines (EudraLex Volume 4). It is at these points that sustainability initiatives in life sciences manufacturing typically stall:
- The CSRD (Directive (EU) 2022/2464) requires standardized sustainability reporting on greenhouse gas emissions across Scope 1, 2 and 3. Without reliable material and energy data from production, this reporting obligation cannot be met.
- The environmental footprint of production remains invisible because no systematic material flow analysis exists. Energy, water, solvents and waste volumes are not captured as controllable levers but accepted as a given.
- Pharmaceutical synthesis is material- and solvent-intensive. Without Process Mass Intensity as a metric and without a green chemistry evaluation of synthesis routes, the greatest reduction lever goes unused.
- Sustainability measures fail because their impact on the validated state is assessed too late. A solvent substitution or equipment retrofit can trigger a revalidation under Annex 15 that, without an early risk assessment per ICH Q9, only surfaces shortly before implementation.
- The Pharmaceutical Quality System under ICH Q10 provides for continual improvement, but without linking sustainability measures to change control and an environmental management system per ISO 14001, they remain isolated actions rather than part of a managed system.
Services
How we support you
Sustainability Assessment & Material Flow Analysis
Analysis of the environmental footprint of production based on energy, water, waste and solvent data, Process Mass Intensity calculation for the processes, and a prioritized list of levers. The outcome is a quantified material balance with identified reduction potentials.
Learn more →Green Chemistry & Process Optimization
Evaluation of synthesis routes according to green chemistry principles: solvent substitution, atom economy and waste reduction in synthesis, with every change managed through change control under the EU GMP Guidelines (EudraLex Volume 4). The outcome is an evaluated list of measures with a change control path and PMI impact per measure.
ESG Roadmap & CSRD Data Foundation
Target setting for Scope 1-2-3 emissions, a measures portfolio, investment planning and a KPI system for sustainability reporting under the CSRD (Directive (EU) 2022/2464). The outcome is an ESG roadmap with a metrics framework and a traceable data foundation for the report.
Circularity & Waste Management
Concepts for reducing and recovering production waste: solvent recovery, wastewater treatment and packaging reduction, aligned with GMP requirements. The outcome is a circularity concept with concrete material streams and recovery pathways.
Environmental Management System & Life Cycle Assessment
Establishment or integration of an environmental management system per ISO 14001 and preparation of life cycle assessments per ISO 14040/14044 for products or processes. The outcome is a documented LCA methodology and an audit-ready environmental management framework.
Greenhouse Gas Accounting Scope 1-3
Capture and accounting of greenhouse gas emissions per ISO 14064 across all three scopes, including the definition of system boundaries and data sources. The outcome is an auditable GHG inventory as the basis for the CSRD report and reduction targets.
How we work together
What it comes down to
Sustainable production in a GMP environment is less a question of the goal than of sequencing. The greatest reduction lever usually lies in synthesis: solvents dominate the Process Mass Intensity, that is, the material input per kilogram of product. Substituting solvents here or improving atom economy reduces resource consumption and waste at the same time. But these very measures touch critical process parameters and thus the validated state. The decisive assessment is therefore not whether a measure has an environmental effect, but whether it triggers a revalidation under Annex 15 via the change control system of the EU GMP Guidelines (EudraLex Volume 4). This risk assessment per ICH Q9 belongs at the beginning. It shifts the effort to where changes are inexpensive, rather than into a late revalidation that eats the savings back up.
The second bottleneck is the data foundation. The CSRD (Directive (EU) 2022/2464) requires reliable figures on Scope 1, 2 and 3, and the most difficult part is the Scope 3 emissions along the supply chain, which cannot be measured internally. An ESG roadmap that formulates targets before material, energy and supplier data have been captured produces reporting figures without a foundation. We build the accounting methodologically per ISO 14064 and link it, through an environmental management system per ISO 14001, to the Pharmaceutical Quality System per ICH Q10. This makes sustainability part of a managed system with change control and CAPA, rather than a collection of isolated actions that fall apart in an audit.
Our approach
Our approach
Step
Result
Sustainability Assessment
Quantified material balance covering energy, water, solvents and waste, with a prioritized list of levers and Process Mass Intensity values per process.
Target Setting & ESG Roadmap
Defined Scope 1-2-3 targets, a measures portfolio and a KPI system, linked to the CSRD reporting obligation under Directive (EU) 2022/2464.
Measure Evaluation & Change Control
Evaluated measures with a risk assessment per ICH Q9 and a change control path under the EU GMP Guidelines, including clarification of the revalidation need under Annex 15.
Implementation & Validation
Implemented measures with documented impact on the validated state, with revalidation carried out wherever it was triggered.
Monitoring & Reporting
KPI monitoring in operations, an auditable GHG inventory and a data foundation for CSRD reporting.
Common pitfalls
Where projects commonly fail
The impact on the validated state is checked too late.
A solvent substitution or equipment retrofit is selected technically before the change control path under the EU GMP Guidelines has been assessed. The triggered revalidation under Annex 15 eats up the savings because it only surfaces shortly before implementation.
The CSRD data foundation is not in place.
Scope 1-2-3 targets are formulated without the material and energy data from production being reliably captured; the report under Directive (EU) 2022/2464 then lacks a traceable data basis, especially for the hard-to-capture Scope 3 emissions.
Green chemistry measures are launched without prior regulatory clarification.
A changed synthesis route or a different solvent can entail a regulatory assessment and, where applicable, a variation to the marketing authorization; without early alignment, a conflict arises between the sustainability goal and the authorization status.
Process Mass Intensity is measured as a metric but not coupled to measures.
A PMI value alone steers nothing; without assigning reduction levers to specific process steps, the metric remains a reporting figure with no effect on resource consumption.
Sustainability runs parallel to the quality system rather than within it.
Measures are operated outside of change control and CAPA and are not linked to an environmental management system per ISO 14001 or the Pharmaceutical Quality System per ICH Q10. As a result, they remain isolated actions that cannot be traced in an audit.
FAQ
Frequently asked questions
Sources
- Directive (EU) 2022/2464 (CSRD) - primary text on sustainability reporting
- EU GMP Guidelines (EudraLex Volume 4) - Change Control and Annex 15 (Qualification and Validation)
- ICH Q9 (Quality Risk Management), ICH Q10 (Pharmaceutical Quality System)
- ISO 14001 (Environmental Management Systems), ISO 14040/14044 (Life Cycle Assessment), ISO 14064 (Greenhouse Gas Accounting)
- Writer source material Sustainable Manufacturing (manufacturing-supply-chain)
- https://theentourage.de/expertise/sustainable-manufacturing/
Life Science Journal
Regulatory updates, straight to your inbox.
New requirements, authority decisions and practice notes. Once a month, unsubscribe any time.
Case Studies
What this looks like in practice
Related insights
All insights →Regulations & standards considered
- Directive (EU) 2022/2464 (CSRD - Corporate Sustainability Reporting Directive)
- EU GMP Guidelines (EudraLex Volume 4)
- EU GMP Guidelines (Change Control / Quality Change Management)
- EU GMP Guidelines Annex 15 (Qualification and Validation)
- ICH Q9 (Quality Risk Management)
- ICH Q10 (Pharmaceutical Quality System)
- ISO 14001 (Environmental Management Systems)
- ISO 14040/14044 (Life Cycle Assessment)
- ISO 14064 (Greenhouse Gas Accounting)
Related topics
Energy & Resource Management →
Energy and resource optimization as the operational part of the sustainability strategy
Lean Manufacturing →
Waste reduction with a direct contribution to resource efficiency
Continuous Improvement Programs →
A culture of improvement as an enabler for sustainable transformation
CAPEX Consulting →
Investment planning for sustainable facilities and technologies
Have a concrete project?
Briefly outline your situation. We'll respond with an initial assessment, usually within one business day.
Prefer direct? +49 89 4161170-0
info@theentourage.de
- Reply usually within one working day
- 4 offices: DE · CH · IT · US
- 100% life sciences